These findings, together with the ability of chemical inhibitors of FASN activity such as C75 to recapitulate the anti-mammosphere activity of the ACACA inhibitor soraphen A, also confirm that de novo fatty acid biogenesis, a pathway that is frequently deregulated during breast carcinogenesis, plays a functional role in CSC self-renewal and survival. This evidence concerns the gene FASN and medical procedure.